Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has submitted to NSE and BSE copies of newspaper notices published on February 25, 2026, in Business Standard (English) and Nava Telangana (Telugu). The notices relate to the completion of electronic dispatch of a Postal Ballot Notice and details of remote e-voting. This follows an earlier company letter dated February 24, 2026. The communication was signed by B. Adi Reddy, Company Secretary, as a routine stock exchange compliance filing.
This is a routine regulatory disclosure informing shareholders about an ongoing postal ballot and remote e-voting process. Shareholders should review the postal ballot notice and exercise their voting rights within the e-voting window. No material impact on stock price is expected from this disclosure alone.